Skip to main content

Table 2 Comparison of two groups by using the EORTC QLQ C30 and BR23 questionnaires

From: Comparison of breast cancer patients who underwent partial mastectomy (PM) with mini latissimus dorsi flap (MLDF) and subcutaneous mastectomy with implant (M + I) regarding quality of life (QOL), cosmetic outcome and survival rates

 PM + MLDFM + Ip value
Global health statusa83.3 (0–100)83.3 (33.3–100)0.21
Physical functiona86.6 (26.6–100)93.3 (33.3–100)0.012
Role functiona100 (0–100)100 (50–100)0.053
Emotional functiona83.3 (0–100)83.3 (33–100)0.705
Cognitive functiona100 (0–100)100 (0–100)0.175
Social functiona83.3 (0–100)66.6 (17–100)0.205
Financial problemsb33.3 (0–100)33.3 (0–100)0.58
Dyspneab0 (0–100)0 (0–66.6)0.483
Painb16.6 (0–100)16.6 (0–100)0.155
Nausea/vomitingb0 (0–66.6)/3.040 (0–16.6)/0.290.024
Fatigueb33.3 (0–100)33.3 (0–88.8)0.214
Sleep disturbancesb0 (0–100)/21.10 (0–100)/14.80.057
Appetite lossb0 (0–100)0 (0–66.6)0.384
Constipationb0 (0–100)0 (0–100)0.663
Diarrheab0 (0–100)0 (0–67)0.155
Systemic therapy side effectsb11 (7–28)11 (7–24)0.858
Arm symptomsb22.2 (0–100)22.2 (0–78)0.511
Breast symptomsb8.3 (0–100)0 (0–67)0.055
Upset by hair lossb6.38 ± 15.234.35 ± 15.040.440
Body imagea75 (0–100)58.3 (0–100)0.000
Future perspectivea66.6 (0–100)66.6 (0–100)0.926
Sexual functiona4 (1–12)4 (2–12)0.165
Sexual enjoymenta5.34 ± 14.333.37 ± 12.240.298
  1. Mann-Whitney U test
  2. athe higher values indicate higher level of functioning and quality of life; min: 0, max: 100
  3. bthe higher values indicate a greater severity of symptoms, min: 0, max: 100